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This .study sought to determine whether clinical variables can he
used Ia
identify patients at high risk of recurrent sponlaneoas
myocardial ischemia or hemodynamic compromise during the 151
4 days after intravenous thrombolycis for oswte myocardial in-
farction . Of 288 patients randomly assigned to a conservative
pusnhrombulysis strategy, 54 (19%) required m4ent cardiac
catheterization within 24 h; 75 126%I underwent urgent eardlae
catheterization within 4 days of admission. Of the clinical varia .
bles examined by multiple logistic regression analysis, only patient
age and anterior wall myocardial infarction correlated with the
need for urgent cardiac catheterization (p = 0.016 and p =
0.017, respeclively) . Compared with recombinant tissue-type plas .
minogen activator or urokinase monotherapy, crombmattoo deer
.
spy with these agents was associated with a lower need far acute
intervention during the let 24 h after admission, but Ihedifference
did not reach statistical significance 114% for ex nbination therapy
vs
. 21% for each agent alone, p = 0 .30) .
Of the 75 patients undergoing urgent coronary anglography,
only 397, had an occluded infarct-related artery . Emergency
Optimal management of acute myocardial infarction after the
early administration of fibrinolytic therapy remains contre-
versial . The value of immediate coronary angioplasty of
residual infarct-related vessel stenosis was investigated in
three randomized controlled clinical trials (2-4) . In contrast
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coronary angioplasty was performed in 49% of me patients and
coronary artery bypass graft surgery was performed urgently In
3% . Despite these interventions, the need for urgent cardiac
calbeteriration was associated with an in-hospital mortality rate of
7 % (vs. 3 % in the group not requiring urgent angiography, p =
0 .36); mean left ventricular ejection fraction was $0 .5 z 11% (vs .
54.3 t 10.89, p = 0 .12) and regional infarct zone wall motion
was -2 .68 t 1 .07 BDlella d (vs . -2,46 t 1 .19 SDlchord; p =
0 .44).
These data suggest that a relatively large proportion of patients
treated conservatively after tlramholylc therapy require early
triage to urgent coronary aaglography ; 2) baseline clinical char .
acferislics are poorly predictive of the need for urgent mterven-
lion ; end 3) despite ready access 1o facilities for aggressive
Intervention, the In.hosplial clinical outcome of this group of
patients appears to be poorer than that of patients without
minimal ischemie or hensodynamk instability .
fJ Am Calf Cardiol 1991;18
:1594-601)
to earlier nonrandomized
studies,
which suggested that this
strategy reduced the risk or cerocclusion and reinfarction (5)
and improved the rate and extent of left ventricular func-
tional recovery (6), each of these three trials concluded that
immediate coronary angioplasty after successful recombi-
nant tissue-type plasminogen activator (rt-PA) therapy was
associated with a higher incidence of procedural complies-
lions and a hither requirement fur blood transfusion than
those associated with a deferred angioplasty strategy . The
more aggressive strategy also failed to reduce in-hospital
morbidity and mortality and was associated with no increase
in left ventricular functional recovery .
More recently, the need for any postthrombolytic inter-
venlion, including coronary angiography, has been ques-
tioned
)7
.B). This issue was specifically addressed in the
Fifth Thrombolysis and Angioplasty in Myocardial Infarc-
11715 .Ir9719163 .5a
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lion trial (TAM-5) (1) . In this ra^domized controlled study .
three intravenous thrombolytic regimens let-PA alone
.
urokinase alone and combined urokinase and rt-PAI were
compared. In addition, patients enrolled in the study were
randomly allocated to either immediate or delayed predis-
charge coronary angiography . The overall findings of the
trial have been previously published
(1) .
The principal aim of
the present analysis was to determine whether clinical va n-
ables available at the time of admission can be used to
identify the subgroup of patients allocated to a strategy of
deferred angiography who are likely to subsequently require
urgent cardiac catheterization for recurrent myocardial is-
chemia or hemodynamie compromise
. The ability to predict
this need would have important implications for patient
management, particularly for the triage of pati~ :nts present-
ing to community hospitals . The secondary aim of the study
was to compare the clinical outcome of this group of patients
with that of patients who remained in stable condition
throughout the hospital course .
Methods
Patient selection. Between April 1988 and May 1989 . 575
patients were enrolled in the TAMI-5 study . Patients were
eligible for recruitment if they presented to one of the
participating institutions (7 main centers and 20 community
hospitals) within 6 h of symptom onset and had associated
unequivocal electrocardiographic (ECG) changes of acute
myocardial infarction . These changes included >0
. 1-mV ST
segment elevation in two or more contiguous leads or ST
segment depression in leads V
I
to V, consistent with poste-
rior wall infarction . Patients were ineligible for enrollment if
they were >75 years of age and had a history of previous
coronary artery bypass graft surgery or prior Q wave myo-
cardial infarction in the same myocardial distribution . They
were also excluded if they had contraindications to throm-
bolysis, including recent active genitourinary or gastrointes-
tinal bleeding, recent major surgery or organ biopsy, previ-
ous stroke or transient ischemic episode, uncontrolled
hypertension or prolonged cardiopulmonary resuscitation .
In addition, patients were excluded if, on admission, the
.,
were ii. cardiogenic shock . defined as a systolic blood
pressure <80 mm Hg in the presence of an adequate left
ventricular filling pressure.
Treatment regimen. Using a 3 x 2 factorial design, each
patient enrolled in the study was andomly assigned to one of
three thrombolytic regimens and to one oft- intervernitual
strategies . The thrombolytic agents employed were ri-PA
and urokinase, given alone or in combination . When given
alone, rt-PA was administered intravenously as a bolus dose
of 10 mg followed by 50 mg over the next I h and an
additional 20 mg during each of the next 2 h for a total dose
of 100 mg. Uookinase, when given alone, was infused at a
rate of 1 .5 million U over 2 min . followed by an additional
1 .5 million U over the next I F. . When ': en in combination,
n-PA, I mg(kg. was given over I h I IV; as an initial bolus
1595
dose, with a maximal total dose of 90 mg) with urokinase . 1 .5
million U . over I h through a separate intravenous infusion
line.
Ajter ,it ion to a tlvombolrtir regimen . each patient
was randomly assigned to either immediate cardiac catheter-
ization and mechanical reperfusiontherapy (coronary angie-
plasty or cot ovary artery bypass graft surgery) as considered
necessary in - 287). or to deferred predischarge cardiac
catheterization in
-
2881 . Those patients allocated to the
inrrnediate cardiac catheterization strategy were transferred
to the catheterization laboratory as soon as possible after
enrollment . Coronary patency wss determined 90 min after
the initiation of the thrombolytic infusion . Patients with a
persistently occluded infarct-related artery (Thrombolysis in
Myocardial Infarction trial ITIMII flow grade 0 or i) 90 min
after the initiation of fibrinolytic therapy were considered for
rescue coronary angioplasty if they had suitable coronary
anatomy . Patients with ongoing myocardial ischemia and
anatomy deemed unsuitable for coronary angioplasty were
referred for urgent coronary artery bypass graft surgery .
Repeat cardiac catheterization was performed before hospi-
tal discharge to evaluate changes in global and regional left
ventricular function and to document infarct-related vessel
potency .
71a,
?SS prrty rus allocated to the nlrernnvre, more <'crr-
rr,0ire ;trout?' of delayed catheterization were admitted
to the corumary care unit and treated with a prespecified
medical regimen that included intravenous lidocaine . intra-
venous h eparin . an oral calcium channel antagonist and
aspirin . A beta-adrenergic blocking agent was not given
routinely but was prescribed as indicated for systemic hy-
pertension, recurrent ischemia or supraventricular tachycar-
dia . Patients in this group did not undergo cardiac catheter-
izntion until i to 10 days after admission unless they
developed one or more of the following : I I recurrent myo-
cardial ischemia. defined as recurrent ischemic chest pain
lasting >20 min
: 2) new ST-T wave changes : 3) new mitral
regurgitation or clinical evidence of moderate or severe
acute pulmonary edema: and 4) persisting hypotension,
defined as e systolic blood pressure <90 mm Hg (or the need
for inotrupic support) for >1 h . To facilitate the identifica-
tion of factors that may predict the need for urgent cardiac
catheterization . the clinical characteristics of the patients
who remained in stable condition throughout their hospital
course were compared with the characteristics of the group
requiring urgent cardiac catheterization within 24 h and with
the total group equiring intervention during the 1st 4 days
after admission
. For the sake of simplicity . curse latter
group\ arc referred to as having "crossed over -" to emer-
gency cardiac catheterization from the intended conserva-
tive management plan .
Cardiac catheterization- In all patients . contrast left yen.
triculography was performed in the 30° right anterior oblique
projection . Global left ventricular ejection fraction and re-
gional wall motion analyses were performed with use of the
area-length 191 and centerline chord (10) methods . respec-
1 596 MULLER ET AL. .
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Figure r . Cumulative incidence of crossover to acute intervention
during the Ist 4 days otter hospital admission in 75 patients .
lively . End-diastolic and end-systolic frames were selected
for analysis by an experienced observer unaware of the
patient's assigned thrombolylic regimen or intervention
strategy . Selective coronary angiography was performed in
multiple left and right anterior oblique projections and the
severity of coronary artery stenosis was quantitatively de-
termined using a validated computer-automated system
(11) .
Statistics. All values are expressed as mean values
I SD or median (25th and 75th percentiles) unless otherwise
stated . Global left ventricular function and regional wall
motion were compared between the groups with the
Wilcoxon rank-sum test ; chi-square analysis was used to
compare mortality rates . Sixteen clinically derived variables
were selected for univariable logistic regression analysis to
identify factors associated with the need for urgent invasive
evaluation and coronary intervention ; five variables that
appeared to be associated with the need for crossover were
then selected for inclusion in a multivariable logistic regres-
sion analysis. A two-tailed probability (p) value <0 .05 was
considered to be statistically significant .
Results
Baseline demographics and treatment regimen . Of the 288
patients randomly assigned to the relatively conservative
delayed cardiac catheterization strategy, 75 (26%) under-
went urgent cardiac catheterization for recurrent myocardial
ischemia or hemodynamic instability during the 1st 4 days
after admission, with a median time to crossover of 9 h (25th
and 75th percentiles = 7 and 23 h . respectively) (Fig. U ; in
the majority of these patients (72%), cardiac catheterization
was performed within 24 h of admission . Baseline demo-
graphic variables and admission hemodynamics for the pa-
tients not requiring urgent cardiac catheterization, those
requiring angiographic evaluation within 24 h and those
crossing over to urgent angiography during the Ist 4 days
after admission are compared in Table I . No differences are
apparent among the groups in gender distribution or pres-
ence of certain risk factors for coronary artery disease,
including cigarette smoking, hyperlipidemia and systemic
hypertension . Urgent cardiac catheterization was performed
slightly more frequently in patients with diabetes mellitus
(28% vs. 17%). There were no differences in admission heart
rate or systemic blood pressure among the three groups
(Table I) . Similarly, there was no difference in the likelihood
of crossover according to the site of recruitment (Fig. 2).
Those patients who initially presented to a community
hospital were referred for urgent cardiac catheterization
equally as often as patients presenting to one of the larger
referral centers (25% vs . 28%). Urgent angiography was
performed more frequently, however, after acute anterior
than after acute inferior wall infarction (32% vs . 22%, p =
0.04).
Influence of d eatment and clinical variables (Table 2) . No
group differences were apparent in the time from the onset of
Table t
. Baseline Demographic Characteristics and Admision Hemodynamics of 288 Patients
ECU = clectrocardingsuphie
.
CrossovercIDay
In=541
Crossover -4 Days
In =751
No Crossover
Ie=213)
Age u.- x SDI 1yet 57 .4 z 8 585 - 8 58 .1 z 10 .4
7r Men 74
71 75
Coronary risk fuel.,, 1%)
Diabetes mellitus 28 28 17
Systemic hypertension 30 35 44
Hvperlipidemia 25 26 71
Cigarette smoking 63
55 62
trios myocardial inramlion 171 9 9 12
Rest angina
171 28 25 22
ECU infarct location 171
Anlcnor 56 52
39
Interior 44 48 61
Admission hemodywmic,aloes Imeeo
Pulse ram Ibeatslmin3
SDI
75 x 17 77 x I8 76 x 17
Systolic
pressure elm Hg) 1 2 7 x 22 132 t 25 131 x 24
Diortoli~+ pressure Imm Hgl
78 x 16 81 _ 17 81 x 16
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Figure 2
. Relation between site of patient recruitment and referral
for urgent cardiac catheterization . The likelihood of crossover was
the same at peripheral sites as at the main centers . ER = emergency
room ; ICU = intensive care unit.
symptoms to initiation of thrombolytic therapy . Although
the difference was not statistically significant (p = 0 .30). the
need for crossover during the 1st 24 h after admission was
less frequent after combined urokinase and rt-PA therapy
(14%) than after monotherapy with either agent alone (21%) .
This difference was less apparent by the 4th hospital day
(combined therapy 22% vs . urokinase 2617, vs . rt-FA 30%,
p = 0 .40) . Identification of the infarct-related artery did not
predict the need for urgent cardiac catheterization . Cross-
over occurred in 31% of patients with an infarct in the
territory of the left anterior descending coronary artery, 27%
of patients with a right coronary artery-related infarct and
24% of patients with a left circumflex coronary artery-related
infarct. Of the 85 patients in whom the left anterior descend-
ing artery was the infarct-related artery, 259 crossed over
MULLER ET AL .
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Table 2. Thrombolytic Therapy and Angiogrephic Findings in 288 Patients
Figure 3
. lndicatiuns far urgent cardiac catheterization in 72 pa-
tents .
within the Ist 24 h of admission. This compares with I I9 of
the patients with a circumflex artery-related infarct and 18%
of those with an infarct in the territory of the right coronary
artery . Similarly, the presence of multivessel coronary ar-
tery disease . defied as the presence of >_70%c stenosis of the
coronary lumer diameter in two or more of the major
epicardial carol ary arteries. was not predictive of the need
for a careiac cathetenzation (28%c vs . 44% within
n
days of admission) .
Indications for emergency cardiac catheterizatioa (Fig . 3).
In the majority of patients, the primary indication for emer-
gency cardiac catheterization was recurrent ischemic chest
pain . Approximately 60%x, of the patients had new ECG
changes consistent with myocardial ischemia and 809c had
either new ECG changes or hemodynamic compromise . Of
those crossing over within 24 h of admission, systolic
hypotension was documented in 40l and acute pulmonary
edema occurred in 25% .
15th . 50th nr 751h percentile . respectively
. Lath
- c alheieftalion. N A - not ,pplicebie:'flMl = Theombolysis
in Myocardial In6:,tinn trial . r1 -PA - remmhiranl 1i+,ue-type PI
rnoogen stieaier.
Crossover <I [)a,
(a = 1 41
Crossover s4 Days
In =75)
Nb Crossover
in - 2131
Time to therapy MI 3.1 s 1 .1
3 a 1
.2
3 .1 c 1 .2
Treatment group 17,1
Urokinase 21 26 14
n-PA II 30 70
n-PA + umkinise 14
22
78
Time to crossover IhT %7 .6:111.6 v.5;92_
2
3
NA
Infaml-e dated aa,,) 1911
Left anlenar descending
39 35 29
Right ceeon. .
- 51 56
Left circumtlev 12 14
other 1 1
Infarct veswl TIMI grade 0uw locate cmhl I 'l
D '! 29 NA
10 10
NA
29
NA
32 NA
Nn
. ofd-aced ....d, < . r l
01a 1 66
72 56
2' 21 27
II
7 17
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Angingraphie findings and clinical outcome (Table 3) . Of
the 75 patients undergoing emergency coronary angiogra-
phy, only a minority (39%) had an occluded infarct-related
artery (TIM1 grade 0 or I coronary flow) ; 32% had TIMI
grade 3 coronary flow . The distribution of coronary flow
grades was similar in the patients crossing over within 24 h of
admission . The potency status of the infarct-related artery
was not readily predicted by the nature of the indication for
intervention . The infarct-related vessel was patent in 60% of
patients with recurrent chest pain, 45% of patients with new
ST segment elevation and 23% of patients with systolic
hypotension .
Ernergenev coronary angioplasty was performed at the
time ofthe emergency cardiac catheterization in 37 patients
(49%) . Of these, one patient died 24 h after the procedure
and two required emergency coronary artery bypass graft
surgery. An additional I I patients in the crossover group
underwent urgent or elective bypass surgery before hospital
discharge (Fig. 4) and 3 patients who were initially treated
conservatively at the time of the urgent cardiac catheteriza-
tion procedure subsequently underwent emergency coro-
nary angioplasty on the next day . Despite the ready avail-
ability of these mechanical revascularization procedures, the
group requiring urgent intervention appeared to have a
poorer clinical outcome than that of the patients who re-
mained free of recurrent myocardial ischemia or hemody-
namic compromise . The need for urgent intervention was
Figure 4. Patency status (Thrombotysis in Myocardial Infarction
ITIMII
grade flow) of the infarct-rotated artery (IRA) at urgent
cardiac catheterization and subsequent management (emergency
and elective treatment) in 75 patients . Percutancuus transluminal
coronary angioplasty (PTCA) was attempted but was unsuccessful
in four patients who then had elective or emergency coronary artery
bypass graft ICABG) surgery . One patient underwent bypass graft
surgery without an initial attempt at angioplasty.
0
0
7
PTCA -
9
Medical PTCA
CABC
Medical
Table 3. Clinical Outcome of 288 Patients
'At the time of crossover angiography . CAnG = coronary artery bypass surgery
; NA = not applicable ;
PrCA = pcrculancous vanelcninal coronary asgioplasty
associated with somewhat poorer predischarge global left
ventricular function. particularly in the early crossover
greitp Fig. 5) . The left ventricular ejection fraction in this
group was 50.5 ± I I% compared with 54.3 ± )q.8% in the
patients who remained in stable condition throughout the
hospital course (p = 0.12). The severity of regional dysfunc-
tion of the infarct zone was marginally greater in the cross-
over group than in the group without recurrent ischemia
or hypotension (-2 .68 ± 1 .07 vs . -2 .46 ± 1 .19 SD/chord,
p = 0.44), but regional function of the noninfarct zone
was similar in these two groups (0 .35 ± 1 .29 vs . 0.24 ±
1 .26 SD/chord, p = 0.55) . The need for urgent cardiac
catheterization in the 1st 24 h was associated with an
in-hospital mortality rate of 7% compared with 3%a in the
group remaining stable during this period (p = 0 .32) . Each of
the five patients in the crossover group who died had a
patent infarct-related artery (TIMI grade 2 or 3 flow) at the
time of emergency cardiac ca:adtefization .
Predictive factors (Tables •1 and 5). Sixteen clinical, he-
modynamie and treatment variables available to the clinician
at the time of admission of ;he patient to the coronary care
unit were used to identify predictors of the need for urgent
cardiac catheterization within 4 days after admission to the
hospital (Table 4) . Of the factors examined, only patient age
and Utterer infarction were significant variables by multiple
logistic regression analysis (Table 5). The association be-
tween age and the need for crossover was nonlinear with a
progressive increase in frequency with age to a peak inci-
dence in the group of patients aged 60 to 65 years, followed
by a decline in frequency in older patients .
Discussion
The principal findings of this study were that 1) urgent
cardiac catheterization with or without subsequent mechan-
ical revascularization procedures was performed in a rela-
tively large proportion of patients assigned to a conservative
strategy after fibrinolytic therapy, and 2) the need for urgent
intervention was poorly predicted by clinically derived var-
iables. Although some investigators (12,13) have objected to
the use of the term "crossover" to refer to similar patient
subgroups (because the use of emergency cardiac catheter-
ization and mechanical revascularization was an integral
component of the prespecified conservative strategy), we
CloicelSequelac
Crossover
<I Day
In = 541
Crossover s4 Days
In = 751
No Cross vo er
In = 213)
Pulmonary edema/hearl failure 1611 25 21 15
Emergency PTCA 1411' 46 49 NA
Emrrgcocy CABG 1411'
0 NA
Prcdischarge CABG (9) I I 22
Death (7,) 7 3
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figure 5 • Global and regional left ventricular function at
repeat cardiac catheterization 7 days after admission in
288 patients. Although not statistically significant, there
was attend toward better function in the group In = 213)
not requiring urgent cardiac catheterization . I7-RWM =
infarct zone regional wall motion; LVEF = left ventric-
ular ejection fraction .
have used the arm freely for the sake of nomenclatural
simplicity .
Frequency of crossover. The frequency of crossover be-
fore the 5th hospital day (26%) was somewhat higher in this
study than that repor :ed in the Thrombolysis in Myocardial
Infarction (TIMt-2A trial (14) and in the Should We Inter-
vene Following Thrombolysis^ (SWIFT) study (8) . These
randomized studies also evaluated the need fo: and optimal
timing of cardiac catheterization after thrombolylic therapy
(rt-PA and anistreplase, respectively). In the TIM(-2A trial
(14), 12 .2% of 197 patients allocated to a conservative
postlytic strategy underwent urgent coronary angiography
for recurrent ischemia within 5 days of admission and
coronary angioplasty was peformed in approximately 50
of these patients. Conversely, in the TIMI-2B trial 161 .
cardiac catheterization was performed before day 15 in
32.7% of the conservative strategy group ;in 25.8% for
recurrent myocardial ischemia) and coronary angioplasty
mid bypass graft surgery were performed in 13.3% and 6 .6%.
Table 4. Variables Evaluated by Univariable Analysis
Clinical variables
Age
Gender
Diabetes mellitus
Cigaeetre nmeail,g
systemic hypenensien
Hyperlipidemia
Prior myocardial inrmclior
Prior angina peetanl
Cistern of
." angina
Prior beta-blacker therapy
Infarct locution an ateatrncardiugmphy
Hemodynamic variables at adnni -an
Ruse rate
Sysmlic bluad pressure
Diastolic blond prnruaen
Treatment vuriahle,
rare to therapy
'thrumbalytit agent
vlull9R el ,1L
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respectively
. Thus, the frequency of intervention by day 15
in the latter study was not dissimilar from the crossover rate
within 4 days in the current study . In the SWIFT study (8) .
139E of the 403 patients assigned to conservative postytic
therapy underwent predischarge coronary angiography and
revascularization procedures were performed in only 5% .
However, patients enrolled in the SWIFT study were <70
years old and presented within 3 h of their first myocardial
infarction and were thus at relatively low risk of early
complications. Moreover, randomization to invasive or con-
servative postlytic therapy was delayed for up to 24 h from
the administration of thrombolytic therapy, allowing approx-
	mately of eligible patients to be excluded from random-
ization because of hemodynamic instability . In the current
study, urgent cardiac catheterization was performed not
only fur recurrent myocardial ischemia- but also for dini-
callp significant hemodynamie instability with the expecta-
lion than revnscularization in the latter group would prevent
potentially irreversible myocardial failure . These differences
may account for some of the observed differences in fre-
quency of intervention among the studies . It is also likely .
however, that because of divergent therapeutic philoso-
phies, the threshold for early acute intervention ryas lower in
the TAMI trial than in the three other studies .
Predictive factors . Only 2 of 16 clinically available v-
:•
ta-
bic, (patient aye and anterior wall myocardial infarction)
were associated with the need for urgent cardiac catheter-
ization. Each of :iese is unequivocally associated with an
increased morbidity and mortality after acute myocardial
Table 5 . Mullipla Logistic Regression .Analysis : Predictors of the
Need for Urgent Cardiac Catheterization Before Day 5 After
Hospital Admission
Urivariable Multivaeiahle
Variable Chi.Square p Value Chi-Square p Value
Age 9.92 0.019 10
.91 0.0016
Anlcriurmnxardial 4.60
am' 5.66 0.017
infarction
Diabetes mellilu, 3.63
O053 3,18 0.075
1600 MM i
.cs
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infarction (151 . Surprisingly, admission hemodynamic status
was similar in the group of patients requiring emergency
cardiac catheterization within 24 h to that in patients who did
not require urgent evaluation . A history of diabetes mellitus
was associated with a marginally greater risk of clinical
instability . Previous studies (16-18) have noted a higher
incidence of postinfarction angina, infarct extension, he:.rt
failure and a higher mortality rate in diabetic patients
.
Hematologic studies (19) have also suggested that diabetes
may he associated with a hypercoagulable state character-
ized by increased platelet aggregability and impaired fibrin-
olytic activity . Other studies (20,21), however, have failed to
show any relation between diabetes and infarct-related ves-
sel reocclusion or reinfarction after thrombolysis .
The need for early intervention was relatively uncommon
after combination thrombolytic therapy compared with that
after monotherapy with rt-PA or urokinuse alone . This
difference may have been related to greater systemic fibrin
lysis with combination therapy and greater generation of
fibrinogen degradation products, both of which have been
correlated with a reduced incidence of reocclusion 121) . This
finding is also consistent with the lower reocclusion rate of
the infarct-related vessel after combined rt-PA and uroki-
nase therapy observed in both the TAMI-2 pilot study (22)
and in the cohort of patients assigned to the aggressive
catheterization strategy of the TAMI-5 trial (1).
The treat-
ment regimen did not prove to be predictive, however, of the
overall need for intervention within 5 days of admission . The
possibility that combination thrombolytic therapy may have
a salutary impact on early clinical outcome is currently being
further examined in a very large, randomized, controlled
clinical trial of rt-PA alone, streptokinase alone and com-
bined streptokinase and rt-PA therapy (Global Utilization of
Streptokinase and t-PA for Occluded Coronary Arteries
trial) .
in contrast to the TIMI-2B trial (23), in which coronary
angiography and myocardial revascularization procedures
were performed more frequently at sites with cardiac cath-
eterization facilities, referral for argent cardiac catheteriza .
(ion in our study was not dependent on the site of patient
recruitment. However, the interpretation of this observation
is limited by the variable referral patterns of the participating
satellite sites. Whereas some community hospitals trans-
ferred patients as soon as possible to a main center, others
admitted patients locally and transferred them to one of the
main referral centers if their subsequent course became
complicated
or for diagnostic cardiac catheterization before
hospital discharge .
Angiographic findings
. Although all but two patients re-
quiring urgent cardiac catheterization had re nant isch-
mic chest pain or new ST segment elevation, only a
minority (37%) had an occluded infarct-related artery (TIMI
grade 0 or I flow) at the time of emergency cardiac cathe-
terization . One-third of the patients had normal coronary
flow in the infarct-related vessel . The majority (72%) had
minimal or single-vessel disease . These findings highlight the
previously described difficulties of accurate noninvasive
determination of the patency status of the infarct-related
vessel (24) and perhaps the frequent occurrence of intermit-
tent reocclusion and spontaneous recanalization (25). The
use of several potentially valuable noninvasive investiga-
tions, including cardiac isoenzyme determination (26) and
continuous ST segment monitoring (27), is currently being
studied and preliminary data are encouraging . If these tests
can reliably determine infarct-related vessel potency, the
need for emergency cardiac catheterization may be substan-
tially reduced .
The need for intervention was not associated with infarc-
tion in the territory of any specific coronary artery . Infarct.
related vessel reocclusion has been previously shown to
occur more frequently after reperfusion of the right coronary
artery (21,28), perhaps because of the larger caliber of the
vessel, its slower flow and the relative absence of large side
branches . However, in this study, the need for intervention
was not more frequent in patients whose right coronary
artery was identified as the infarct-related artery . One pos-
sible explanation for this observation is that any greater
incidence of reocclusion in the right coronary artery was
balanced by a greater incidence of hemodynamic compro-
mise in patients with a left anterior descending artery-related
infarct .
Impact o! acute intervention on clinical outcome
. The
rationale for urgent angiographic evaluation of patients with
recurrent myocardial ischemia or hemodynamic instability
after thrombolytic therapy is to allow triage of patients to
continued medical therapy or emergency myocardial revas-
cularization if coronary flow is suboptimal. However, this
approach has not been validated in a controlled randomized
fashion . Rescue coronary angioplasty, for example, has been
advocated (29) but has also been associated with a high
incidence of reocclusion, particularly after rt-PA therapy
(2,14), and with the potential to cause hemodynamic insta-
bility and life-threatening rhythm disturbances (30) . None-
theless, urgent coronary angiography does allow patients
with severe triple-vessel or left main coronary artery disease
to be triaged to early revascularization. The impact of this
strategy on subsequent clinical outcome is difficult to eval-
uate. By definition, patients selected for urgent angiography
in our study were at increased risk of in-hospital complica-
tions . It should not be surprising, therefore, that there was a
trend toward a higher incidence of acute pulmonary edema
in this group, worse global and regional left ventricular
function and a higher in-hospital mortality rate . In the
absence of a control group, the positive (or negative) impact
of this strategy on clinical outcome remains speculative .
Limilatlons, Few data are available on the patients who
developed rcrmrent myocardial ischemia or hemodynamic
compromise but did not undergo urgent cardiac catheterize-
Lion either because their condition was too unstable to
permit transfer to the cardiac catheterization. laboratory or
because they died before transfer could be arranged . The
actual number of patients, their management and subsequent
1ACC
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clinical outcome can, therefore, only be estimated, but the
number of patients in this category is likely to be small
.
Conclusions. In our study, urgent cardiac catheterization
was frequently required after conservative postihrombolytic
management, was poorly predicted by clinical variables and
was associated with a relatively poor clinical outcome de-
spite an aggressive approach to myocardial revasculariza-
lion . These findings suggest that better adjunctive medical
therapy is required to prevent infarct-related vessel reocclu-
:ion after successful reperfusion therapy . Furthermore .
more reliable means of noninvasively identifying patients
with a persistently occluded or reoccluded infarct-related
artery are desirable and may obviate the need for invasive
evaluation in a significant proportion of patients . Finally .
randomized controlled trials may be necessary to determine
the optimal method
of treating patients with rcurrent myo-
cardial ischetnia or hemodynamic instability alter reperfu-
sion therapy .
References
I . CdiPRM, Top.] El, Slack R5 . et al . Evalumion of u,mbinmioa thrum .
bolytic therapy and liming of cardiac cathererizavon in acute myecardsd
infarction: rmlrsorThrombolyss and Aogioplutr' in MyocaNiai Inl'zr
lion-Phau 5 randomized trial . Circulation 1991811541-56.
2
. Topoi El, Catiff ifM, Gouge BS . et al . A randomized trial of immediet,
us delayed elective angioplasty after inoavenou, venue pln,mmogen
activator in acute myocardial infarction. N Engl I Med 19X7317 :19
,
-8.
3 . The TIMI Research Group. Immediate v, ddayod carhdnricatior and
angioplasty following Ihrombotytlc therapy for acme myacurdiul infarc-
fidn . JAMA 1988 :109 :970-80,
4. Simoons ML. Amid AER, Betrtu A, et al. Thramhulvsi, with your
plasminogen actuator in route myocardial infarction : no .otdrt:onol
rift from immediate percumne0us cor-mary angioplasty . Lance : 1988. ;.
197-203 .
5 . Meyert, Mess W . Sehmoz H, et al. Prnvaoeeocs ,emstu :ninal cvon,ry
angioplasty immediately afro, intracoreriry vreptol,,i, of Irromurl
myocardial tnfurctiun. Circulation 193':66:905-13.
6
. Hi nzlur G, Rmherford BD, MaCunahay DR, or al oercul'aneau, trm-
luminal coronary angioplasty with and withom thrombalytic therapy for
treatment of acute myocardial infarction. Am Been J 1981 :106',95;
-71 .
7. The TIM[ Studv Group. Comparison of iii-iv and conursdive ,trot .
onion after irealmrnl with intravenous tissue pia.minogeu anicator is
e myocardial inrerdion : resuhn er the Thromh,b'sis in Myoc :rrd,al
Infarclioo ITIMIt phase 111rial, N East I Slat I. T21)6IM--27
X. SWIFT (Should We Inrervene Following Thrombolyxiv't Trial Study
Group. SWIFT trot of delayed etecrice inte,ention v+
treatment after thromboty515with onl,treplaseInac,ltemyecatvr,it nhuo
non, Br Med J 1591 :102555-60 .
9, Sander H, Dodge HT. The use of ample piano n igi-rdi .grm, for the
calculation of tell -a-In, votumc in man . Am Heart 11963'115-14 .
10. Sheehun EH. Boson EL . bays HT . slather D(,. J, W- P .,
Advanlaros and emidi-ton, of the centerline method far eharmE . .eng
regional ventricular function . Circulation 198fi'4 :'.91-1115 .
II
. Mancini GBJ . SImon 513 . McGulem hIt . Leiree Mt . Fricdman H7
.,
Vogoi RA. Aummared quaoriwtive coronary anpa,pmphy mprphplogi.
dphv,iol ' . .. .I ;d:a no,f, pidd ;e,al ;ol ;ogrph,o-hod .
Circulation 1987,1515]-F0 .
14(11
L . loin DS. Braunnald F
. Foil F
. e1 al. The Thrombulysis in Myocardial
tutorliun iTIS111 riot phase It
. additional information and perspectives.
1 Am Cull Cmdwl 1990.17.1184-92.
I1 Sleight P Do vu . sod to inturvona utter throrobotritv ii routi ruiocard,al
Infartion'Circutuuon 1990(SCI707-9.
14 . Ro. . ..Wi BamDS.Gore]Stetot Comp
:msonoflmmedlmeimavv4e
delayed m,asne . and ooruenative strateg¢s after ussuo .typc plasm,no
.
irotor: results of the Thrombolyvs in My,xardivl Intarctwo
ITIStt pha,o 11-A trial . Circulation 1990:8LI457-',6
.
L ISIS' Collaborance Gonp. Randomised trial of introrovous ,treptokJ-
•
, rd , orpnin . both or neitheramong 17 .102 cases of suspc01n1 acwc
cordial infarction: ISIS 2 . Lancet !9X3:2:349-W.
16 South JW . Slnrebs ii . Serokman R . and the Sultimnler Poslinierctiun
Rv,earch Group . Pmenosis of patients ,ilh diaber, volute, afro, a- e
• cordial Intnct
;on. Am J Cardiol 1984.54 718-_'I.
17 Ahbml RD . Donuhue RP. Kannel WB, Wilhon PWF . The impact of
diabetes
oa ounival following myocardial infarction', men v, aomrn .
t osts 1988460: :86-W .
18. S'or, P11 . Sutler J E Hart-1 l T, or al. The moor of diabetes mdlitm' on
proem,i, opal ,crtal [of, ventricular function atle, acute m iocardi,il
mfarotion'n anmbuvon of both corona, disease and dia4olicleft ven-
tricular Jt,iund,ua to the adverse profrosic . 19m Cull Cardiol 1969 :14 :
19 . Grc c, SI . Prove, FE . Hemonatic abnu :realitie>in didbetics .In: J,rrd
RL vd . Diatwte, rod Hewn Diseases .Am,erdam . Ehecier. 1981:4'-30 .
'0 . Elli, SG. Tonal EJ. George BS, et al. Recurrent ischemla without
• m :Jcsu of risk foams for in-hn;pil:d i;chemic
runny
tonowing
- e„ fullhrombol,,ls with intnPKnonr (Sore pla0mloegen aetivamr .
Crculanon 1989811'1159-65,
21 . Ohman ESL Coin RSL Top,] El, et ,1 . Coroegnence, of -1-m,
alter --,ml rcperfu,ira therapy in utme in-a :dvd infacct,en. Go-
cwle-eon 1W08' 7-91,
` . Topol EL Cniiff RSI, George BS . eI a1. Cora-arterial ilameddly,i,
uhh combined info,ion of recomhinanr tis,ne-type plarminnpen activator
and urokm; m paves, w .in acute mlcan0ul mtarcuun . Clrcutol,ve
1984
:77:1111-7 .
_I. Felt I . Mull,, HS, Braununld F. d al. Thrombobsis 1n Slyocxrdial
Infarnon 13151t1 phase II tnul : uuteome wmparison of a 'vonsenmive
u eon; lenimyhospital , 1 .Am Coll Cardiol
1'159116.11
s_i~
mm
'4 . Klrchcn BE, Top it El . (J'Neill WW. n, S . Fredievon oforf	amnn
naur, n,ft,, ,n,r,.enm„mr9mhdy,ic,eeo,py.AmJCur-
dtol i9X7
;
,9's1' 9
-5 . Hooker D, D-- 6, Chi-he, S, Sts A . InenniHenl c
,cdus, myacaNialinfarc n fcombinedthrombvlgtic
opal atsedd,nnf therapy. N End J Sled 1987317 105_,-9.
'_6. Poke PR . Guadagno PA, Ruinert, R, of al, Early 'lingrosi, of acute
wanli :it inlarnmn hosed on ocnar of,ubf,,,m, of cr,,Iine ki ...e Mir
0rculacnn 199441759_61.
27 Krcod' MW. Wiener NB . Pope JE, el al. The portable programmable
II-op rocc„or.driven rcutdime 12 lead electrocardiogrph ;c monitor : a
pmlimiuc.. report of a new device for the noninvasive detection of
rp43'u,ior or silent coro ry rwclusion
. Am J Cordial
'X . But,, ER . Reputusinn therapy in inferior myncrrdial infarction
. 1 Am
Cod Cardiul I988 :II :44A-51A .
'9. rag R4, Tnp01 at, George BS, el al. C6arader, ;ics and outcome of
raft, in whom,eperfunion with ininnernus Iissoc-type ptasmeregen
aCIB1110r faill'
. K,aln o(111e TM1mmboltois and dngmplaaty In M1tyo-'.mdial
mrara,on,TAhu, 1 mat . Ci-lan- loss 77--4
III. ooh Gbt Topvl Eu Sudden paradome olmcal detenorzr,vn during
eiopla,ly pf the occlsded right coronary artery in acute myocardial
InfdrelloE
I Am Coll C7td1111989i'1
;1 :0:-9.
